Not only does eligibility criteria consider size and number, but it also considers tumor biology (including tumor markers such as alpha-fetoprotein (AFP) levels [18,19]), transplant benefit (i.e., the survival on the waitlist and after LT), and the availability of donor organs [20,21,22,23]. Here, AFP is linked to neoplasm.